Sandoz Aktie

36,70CHF -0,62CHF -1,66%
Sandoz für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN DE: SANDOZ / ISIN: CH1243598427
<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 0 0 0 20 000 23 000
Umsatz pro Mitarbeiter in Mio. EUR 0,00 0,00 0,00 0,45 0,40

Bilanz (in Mio. CHF) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 4 988 5 071 5 529 6 373 7 070
Summe Anlagevermögen 10 875 10 913 10 715 9 980 10 971
Summe Aktiva 15 863 15 983 16 244 16 353 18 041

Bilanz (in Mio. CHF) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 9 037 8 546 8 139 9 070 10 642
Summe Eigenkapital 6 827 7 438 8 105 7 284 7 399
Summe Passiva 15 863 15 983 16 244 16 353 18 041

Adresse

Suurstoffi 14, 6343 Rotkreuz
Internet http://www.sandoz.com

Management

Aarti S. Shah
Independent Director
Christophe Delenta
President-Europe
Claire D'Abreu Hayling
Chief Scientific Officer
Gilbert Ghostine
Chairman
Glenn A. Gerecke
Chief Manufacturing & Supply Officer
Graeme David Pitkethly
Independent Director
Ingrid Sollerer
Chief Compliance Officer & Group General Counsel
Ioannis Skoufalos
Independent Director
Karen J. Hübscher
Vice Chairman
Keren Haruvi
President-North American Region
Kirsten Harting
Chief Medical Officer
Maria Rosaria Varsellona
Independent Director
Marta Vlatchkova
Chief Accounting Officer
Mathai Mammen
Independent Director
Michael Rechsteiner
Independent Director
Peter Stenico
President-International Region
Pierre Bourdage
Chief Commercial Officer
Rebecca Guntern Flückiger
Chief Commercial Officer
Remco J. Steenbergen
Chief Financial Officer
Richard Saynor
Chief Executive Officer
Shamiram R. Feinglass
Independent Director
Tripti Jha
Chief People Officer
Urs Riedener
Independent Director